Generation of three induced pluripotent stem cell lines from patients with glycogen storage disease type III
Lucille Rossiaud1, Emilie Pellier2, Manon Benabides2
1CECS, I-Stem, Corbeil-Essonne 91100, France; INSERM U861, I-Stem, Corbeil-Essonne 91100, France; UEVE U861, I-Stem, Corbeil-Essonne 91100, France; Genethon, 91000 Evry, France; Université Paris-Saclay, Univ Evry, Inserm, Genethon, Integrare research Unit UMR_S951, 91000 Evry, France.
Abstract:
Glycogen storage disease type III (GSDIII) is an autosomal recessive disorder characterized by a deficiency of glycogen debranching enzyme (GDE) leading to cytosolic glycogen accumulation and inducing liver and muscle pathology. Skin fibroblasts from three GSDIII patients were reprogrammed into induced pluripotent stem cells (iPSCs) using non-integrated Sendai virus. All of the three lines exhibited normal morphology, expression of pluripotent markers, stable karyotype, potential of trilineage differentiation and absence of GDE expression, making them valuable tools for modeling GSDIII disease in vitro, studying pathological mechanisms and investigating potential treatments.
More Related Videos
Related Concept Videos
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Somatic...


